Advertisement
Screener

Exelixis Inc (EXEL) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Exelixis Inc Shares Authorized

Exelixis Inc (EXEL) had Shares Authorized of 400.00 million shares as of 2026-07-03, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-05

  • 2026-07-03: Common Stock, Shares Authorized 400.00M shares.
  • 2026-04-03: Common Stock, Shares Authorized 400.00M shares.
  • 2026-01-02: Common Stock, Shares Authorized 400.00M shares.
  • 2025-10-03: Common Stock, Shares Authorized 400.00M shares.
Period endCommon Stock, Shares Authorized
2026-07-03400.00M shares
10-Q · filed 2026-08-05
2026-04-03400.00M shares
10-Q · filed 2026-05-05
2026-01-02400.00M shares
10-Q · filed 2026-08-05
2025-10-03400.00M shares
10-Q · filed 2025-11-04
2025-07-04400.00M shares
10-Q · filed 2025-07-28
2025-04-04400.00M shares
10-Q · filed 2025-05-13
2025-01-03400.00M shares
10-K · filed 2026-02-10
2024-09-27400.00M shares
10-Q · filed 2024-10-29
2024-06-28400.00M shares
10-Q · filed 2024-08-06
2024-03-29400.00M shares
10-Q · filed 2024-04-30
2023-12-29400.00M shares
10-K · filed 2025-02-11
2023-09-29400.00M shares
10-Q · filed 2023-11-01
2023-06-30400.00M shares
10-Q · filed 2023-08-01
2023-03-31400.00M shares
10-Q · filed 2023-05-09
2022-12-30400.00M shares
10-K · filed 2024-02-06
2022-09-30400.00M shares
10-Q · filed 2022-11-01
2022-07-01400.00M shares
10-Q · filed 2022-08-09
2022-04-01400.00M shares
10-Q · filed 2022-05-10
2021-12-31400.00M shares
10-K · filed 2023-02-07
2021-10-01400.00M shares
10-Q · filed 2021-11-02
2021-07-02400.00M shares
10-Q · filed 2021-08-05
2021-04-02400.00M shares
10-Q · filed 2021-05-06
2021-01-01400.00M shares
10-K · filed 2022-02-18
2020-10-02400.00M shares
10-Q · filed 2020-11-05
2020-07-03400.00M shares
10-Q · filed 2020-08-06
2020-04-03400.00M shares
10-Q · filed 2020-05-05
2020-01-03400.00M shares
10-K · filed 2021-02-11
2019-09-27400.00M shares
10-Q · filed 2019-10-30
2019-06-28400.00M shares
10-Q · filed 2019-07-31
2019-03-29400.00M shares
10-Q · filed 2019-05-01
2018-12-28400.00M shares
10-K · filed 2020-02-25
2018-09-28400.00M shares
10-Q · filed 2018-11-01
2018-06-29400.00M shares
10-Q · filed 2018-08-01
2018-03-31400.00M shares
10-Q · filed 2018-05-02
2017-12-31400.00M shares
10-Q · filed 2018-05-02
2017-12-29400.00M shares
10-K · filed 2019-02-22
2017-09-30400.00M shares
10-Q · filed 2017-11-01
2017-06-30400.00M shares
10-Q · filed 2017-08-02
2017-03-31400.00M shares
10-Q · filed 2017-05-01
2016-12-31400.00M shares
10-Q · filed 2017-11-01
2016-12-30400.00M shares
10-K · filed 2018-02-26
2016-09-30400.00M shares
10-Q · filed 2016-11-03
2016-06-30400.00M shares
10-Q · filed 2016-08-03
2016-03-31400.00M shares
10-Q · filed 2016-05-04
2015-12-31400.00M shares
10-K · filed 2017-02-27
2015-09-30400.00M shares
10-Q · filed 2015-11-10
2015-06-30400.00M shares
10-Q · filed 2015-08-11
2015-03-31400.00M shares
10-Q · filed 2015-04-30
2014-12-31400.00M shares
10-K · filed 2016-02-29
2014-09-30400.00M shares
10-Q · filed 2014-11-04
2014-06-30400.00M shares
10-Q · filed 2014-07-31
2014-03-31400.00M shares
10-Q · filed 2014-05-01
2013-12-31400.00M shares
10-K · filed 2015-03-02
2013-09-30400.00M shares
10-Q · filed 2013-10-30
2013-06-30400.00M shares
10-Q · filed 2013-08-06
2013-03-31400.00M shares
10-Q · filed 2013-05-07
2012-12-31400.00M shares
10-K · filed 2014-02-20
2012-09-30400.00M shares
10-Q · filed 2012-11-07
2012-06-30400.00M shares
10-Q · filed 2012-08-02
2012-03-31200.00M shares
10-Q · filed 2012-05-03
2011-12-31200.00M shares
10-Q · filed 2012-11-07
2010-12-31200.00M shares
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78